DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 384, Issue 2, 2011, Pages 197-207

  Ku, Hui Chun ^a   Chen, Wen Pin ^a   Su, Ming Jai ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

AKT; Cardiac function; Dipeptidyl peptidase 4; Glucagon like peptide 1; Ischemia reperfusion; Pressure volume loops

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL PEPTIDASE IV; EXENDIN[9-39]; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR ANTAGONIST; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; LACTATE DEHYDROGENASE; PROTEIN KINASE B; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART INJURY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFORMANCE; HEART PROTECTION; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE PRESSURE; INSULIN BLOOD LEVEL; LEFT VENTRICULAR ENDSYSTOLIC PRESSURE; MALE; MOLECULAR MECHANICS; NONHUMAN; PRESSURE VOLUME CURVE; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; DIPEPTIDYL PEPTIDASE 4; DISEASE MODELS, ANIMAL; GLUCAGON-LIKE PEPTIDE 1; HEART FUNCTION TESTS; HEMODYNAMICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PEPTIDE FRAGMENTS; RATS; RATS, INBRED F344; RATS, MUTANT STRAINS; SIGNAL TRANSDUCTION;

EID: 79961172510     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-011-0665-3     Document Type: Article

References (46)

1. M Arakawa T Mita K Azuma C Ebato H Goto T Nomiyama Y Fujitani T Hirose R Kawamori H Watada 2010 Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4 Diabetes 59 1030 1037 20068138 10.2337/db09-1694 1:CAS:528:DC%2BC3cXltFSmtL0%3D
2. K Ban MH Noyan-Ashraf J Hoefer SS Bolz DJ Drucker M Husain 2008 Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways Circulation 117 2340 2350 18427132 10.1161/CIRCULATIONAHA. 107.739938 1:CAS:528:DC%2BD1cXltFyltrY%3D (Pubitemid 351653542)
3. K Ban KH Kim CK Cho M Sauve EP Diamandis PH Backx DJ Drucker M Husain 2010 Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor Endocrinology 151 1520 1531 20172966 10.1210/en.2009-1197 1:CAS:528:DC%2BC3cXks1CmtrY%3D
4. JM Barragan RE Rodriguez E Blazquez 1994 Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats Am J Physiol 266 E459 466 8166268 1:CAS:528:DyaK2cXis1Wrtrg%3D
5. S Bhashyam AV Fields B Patterson JM Testani L Chen YT Shen RP Shannon 2010 Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy Circ Heart Fail 3 512 521 20466848 10.1161/ CIRCHEARTFAILURE.109.900282
6. E Boonacker CJ Van Noorden 2003 The multifunctional or moonlighting protein CD26/DPPIV Eur J Cell Biol 82 53 73 12647932 10.1078/0171-9335-00302 1:CAS:528:DC%2BD3sXjt12hsLY%3D (Pubitemid 36285042)
7. AK Bose MM Mocanu RD Carr CL Brand DM Yellon 2005 Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury Diabetes 54 146 151 15616022 10.2337/diabetes.54.1.146 1:CAS:528:DC%2BD2MXhtVWju7k%3D (Pubitemid 40105106)
8. DS Burley SA Hamid GF Baxter 2007 Cardioprotective actions of peptide hormones in myocardial ischemia Heart Fail Rev 12 279 291 17516166 10.1007/s10741-007-9029-y 1:CAS:528:DC%2BD2sXnvFKnt7Y%3D (Pubitemid 350176701)
9. WP Chen HJ Tzeng HC Ku YJ Ho SS Lee MJ Su 2010 Thaliporphine ameliorates cardiac depression in endotoxemic rats through attenuating TLR4 signaling in the downstream of TAK-1 phosphorylation and NF-kappaB signaling Naunyn Schmiedebergs Arch Pharmacol 382 441 453 20848273 10.1007/s00210-010-0562-1 1:CAS:528:DC%2BC3cXhsVKkt7zP
10. BB Dokken WR Hilwig MK Teachey RA Panchal K Hubner D Allen DC Rogers KB Kern 2010 Glucagon-like peptide-1 (GLP-1) attenuates post-resuscitation myocardial microcirculatory dysfunction Resuscitation 81 755 760 20347207 10.1016/j.resuscitation.2010.01.031 1:CAS:528:DC%2BC3cXmtFamuro%3D
11. J Doupis A Veves 2008 DPP4 inhibitors: a new approach in diabetes treatment Adv Ther 25 627 643 18641927 10.1007/s12325-008-0076-1 1:CAS:528:DC%2BD1cXhsVyqtL7K
12. DJ Drucker 2006 The biology of incretin hormones Cell Metab 3 153 165 16517403 10.1016/j.cmet.2006.01.004 1:CAS:528:DC%2BD28Xislyhtr4%3D
13. HC Fehmann R Goke B Goke 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide Endocr Rev 16 390 410 7671853 1:CAS:528:DyaK2MXmslCqtbY%3D
14. AV Fields B Patterson AA Karnik RP Shannon 2009 Glucagon-like peptide-1 and myocardial protection: more than glycemic control Clin Cardiol 32 236 243 19452489 10.1002/clc.20456
15. Y Fujio T Nguyen D Wencker RN Kitsis K Walsh 2000 Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart Circulation 101 660 667 10673259 1:CAS:528:DC%2BD3cXhtlGntLs%3D (Pubitemid 30094738)
16. DJ Grieve RS Cassidy BD Green 2009 Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? Br J Pharmacol 157 1340 1351 19681866 10.1111/j.1476-5381. 2009.00376.x 1:CAS:528:DC%2BD1MXhsVKmu7%2FE
17. R Gros X You LL Baggio MG Kabir AM Sadi IN Mungrue TG Parker Q Huang DJ Drucker M Husain 2003 Cardiac function in mice lacking the glucagon-like peptide-1 receptor Endocrinology 144 2242 2252 12746281 10.1210/en.2003-0007 1:CAS:528:DC%2BD3sXktFehtLg%3D (Pubitemid 36629873)
18. E Hahm YS Lee HS Jun 2008 Suppressive effects of glucagon-like peptide-1 on interferon-gamma-induced nitric oxide production in insulin-producing cells is mediated by inhibition of tumor necrosis factor-alpha production J Endocrinol Invest 31 334 340 18475052 1:CAS:528:DC%2BD1cXnsl2qurw%3D (Pubitemid 351796620)
19. DJ Hearse R Bolli 1992 Reperfusion induced injury: manifestations, mechanisms, and clinical relevance Cardiovasc Res 26 101 108 1571929 10.1093/cvr/26.2.101 1:STN:280:DyaK383ktVKisg%3D%3D
20. F Hua T Ha J Ma Y Li J Kelley X Gao IW Browder RL Kao DL Williams C Li 2007 Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism J Immunol 178 7317 7324 17513782 1:CAS:528:DC%2BD2sXlsVOltb8%3D (Pubitemid 46847459)
21. M Juhaszova DB Zorov Y Yaniv HB Nuss S Wang SJ Sollott 2009 Role of glycogen synthase kinase-3beta in cardioprotection Circ Res 104 1240 1252 19498210 10.1161/CIRCRESAHA.109.197996 1:CAS:528:DC%2BD1MXms1Wks74%3D
22. P Kleinbongard R Schulz G Heusch 2011 TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure Heart Fail Rev 16 49 69 20571888 10.1007/s10741-010-9180-8 1:CAS:528:DC%2BC3cXhsF2htbbN
23. HC Ku WP Chen MJ Su 2010 GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats Naunyn Schmiedebergs Arch Pharmacol 382 463 474 20852989 10.1007/s00210-010-0559-9 1:CAS:528: DC%2BC3cXhsVKkt73O
24. MC Michel E Fliers CJ Van Noorden 2008 Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism? Naunyn Schmiedebergs Arch Pharmacol 377 205 207 18398599 10.1007/s00210-008-0280-0 1:CAS:528:DC%2BD1cXkvVSitbY%3D
25. C Morimoto SF Schlossman 1998 The structure and function of CD26 in the T-cell immune response Immunol Rev 161 55 70 9553764 10.1111/j.1600-065X.1998. tb01571.x 1:CAS:528:DyaK1cXitlyms7o%3D (Pubitemid 28119018)
26. CJ Mullonkal LH Toledo-Pereyra 2007 Akt in ischemia and reperfusion J Invest Surg 20 195 203 17613695 10.1080/08941930701366471 (Pubitemid 47050383)
27. LA Nikolaidis D Elahi T Hentosz A Doverspike R Huerbin L Zourelias C Stolarski YT Shen RP Shannon 2004a Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy Circulation 110 955 961 10.1161/01.CIR.0000139339.85840.DD 1:CAS:528:DC%2BD2cXms1OgtLw%3D (Pubitemid 39128621)
28. LA Nikolaidis S Mankad GG Sokos G Miske A Shah D Elahi RP Shannon 2004b Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 962 965 10.1161/01.CIR.0000120505.91348.58 1:CAS:528:DC%2BD2cXhsFeisbY%3D (Pubitemid 38282847)
29. M Nishihara T Miura T Miki M Tanno T Yano K Naitoh K Ohori H Hotta Y Terashima K Shimamoto 2007 Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection J Mol Cell Cardiol 43 564 570 17931653 10.1016/j.yjmcc.2007.08.010 1:CAS:528: DC%2BD2sXht1amsLrK (Pubitemid 47615050)
30. MH Noyan-Ashraf MA Momen K Ban AM Sadi YQ Zhou AM Riazi LL Baggio RM Henkelman M Husain DJ Drucker 2009 GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice Diabetes 58 975 983 19151200 10.2337/db08-1193 1:CAS:528:DC%2BD1MXktleiu7o%3D
31. K Ohnuma NH Dang C Morimoto 2008 Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function Trends Immunol 29 295 301 18456553 10.1016/j.it.2008.02.010 1:CAS:528:DC%2BD1cXmvVylsLY%3D
32. C Orskov L Rabenhoj A Wettergren H Kofod JJ Holst 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans Diabetes 43 535 539 8138058 10.2337/diabetes.43.4.535 1:CAS:528:DyaK2cXitlKlt7c%3D (Pubitemid 24096293)
33. T Ravingerova J Matejikova J Neckar E Andelova F Kolar 2007 Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart Mol Cell Biochem 297 111 120 17016676 10.1007/s11010-006-9335-z 1:CAS:528:DC%2BD2sXjtVSqsLo%3D (Pubitemid 46443535)
34. D Reinhold A Biton A Goihl S Pieper U Lendeckel J Faust K Neubert U Bank M Tager S Ansorge S Brocke 2007 Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses Ann N Y Acad Sci 1110 402 409 17911455 10.1196/annals.1423.042 1:CAS:528:DC%2BD2sXht1Git7bK (Pubitemid 350043029)
35. M Sauve K Ban MA Momen YQ Zhou RM Henkelman M Husain DJ Drucker 2010 Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice Diabetes 59 1063 1073 20097729 10.2337/db09-0955 1:CAS:528:DC%2BC3cXltFSmtLk%3D
36. GG Sokos LA Nikolaidis S Mankad D Elahi RP Shannon 2006 Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure J Card Fail 12 694 699 17174230 10.1016/j.cardfail.2006.08.211 1:CAS:528:DC%2BD28XhtlaqsrzK (Pubitemid 44881367)
37. DP Sonne T Engstrom M Treiman 2008 Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart Regul Pept 146 243 249 17976835 10.1016/j.regpep.2007.10.001 1:CAS:528:DC%2BD1cXosFKnsw%3D%3D
38. MA Thompson K Ohnuma M Abe C Morimoto NH Dang 2007 CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders Mini Rev Med Chem 7 253 273 17346218 10.2174/138955707780059853 1:CAS:528: DC%2BD2sXitVOitL4%3D (Pubitemid 46488249)
39. CC Tseng XY Zhang MM Wolfe 1999 Effect of GIP and GLP-1 antagonists on insulin release in the rat Am J Physiol 276 E1049 1054 10362617 1:CAS:528:DyaK1MXktlSrtb0%3D
40. JR Ussher GD Lopaschuk 2008 The malonyl CoA axis as a potential target for treating ischaemic heart disease Cardiovasc Res 79 259 268 18499682 10.1093/cvr/cvn130 1:CAS:528:DC%2BD1cXot1Wis7g%3D (Pubitemid 351951618)
41. MG Vila Petroff JM Egan X Wang SJ Sollott 2001 Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes Circ Res 89 445 452 11532906 10.1161/hh1701.095716 1:STN:280: DC%2BD3MvpvFKktA%3D%3D (Pubitemid 34132661)
42. AK Vyas KC Yang D Woo A Tzekov A Kovacs PY Jay PW Hruz 2011 Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy PLoS One 6 e17178 21359201 10.1371/journal.pone.0017178 1:CAS:528:DC%2BC3MXisl2jurc%3D
43. YN Williams H Baba S Hayashi H Ikai T Sugita S Tanaka N Miyasaka T Kubota 2003 Dipeptidyl peptidase IV on activated T cells as a target molecule for therapy of rheumatoid arthritis Clin Exp Immunol 131 68 74 12519388 10.1046/j.1365-2249.2003.02020.x 1:CAS:528:DC%2BD3sXhtFGltr0%3D (Pubitemid 36098824)
44. MM Zaruba HD Theiss M Vallaster U Mehl S Brunner R David R Fischer L Krieg E Hirsch B Huber P Nathan L Israel A Imhof N Herbach G Assmann R Wanke J Mueller-Hoecker G Steinbeck WM Franz 2009 Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction Cell Stem Cell 4 313 323 19341621 10.1016/j.stem.2009.02.013 1:CAS:528: DC%2BD1MXltVeqsro%3D
45. M Zhang L Chen 2008 Status of cytokines in ischemia reperfusion induced heart injury Cardiovasc Hematol Disord Drug Targets 8 161 172 18781928 10.2174/187152908785849116 1:CAS:528:DC%2BD1cXhtVCltbbO
46. T Zhao P Parikh S Bhashyam H Bolukoglu I Poornima YT Shen RP Shannon 2006 Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts J Pharmacol Exp Ther 317 1106 1113 16489128 10.1124/jpet.106.100982 1:CAS:528: DC%2BD28Xlt1eqtL8%3D (Pubitemid 43764114)